Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients (HEPHAISTOS)
This study is currently recruiting participants.
Verified January 2013 by Novartis
Study NCT01551212   Information provided by Novartis

First Received on March 8, 2012.   Last Updated on January 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Transplantation
Interventions listed in this trial
Everolimus (RAD001) as add-on
tacrolimus group
Additional drug interventions recognized in this trial
Everolimus
Sirolimus
Tacrolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Novartis Pharmaceuticals
CROLLL, Winicker Norimed


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services